ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 166199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 166199; 2) Community: the network communities that were significantly associated with the response to NSC 166199; 3) Molecule: the relationships between components within communities and NSC 166199; 4) MDR: the compounds that were significantly associated with the NSC 166199.

NSC Compound Enrichment Correlation
NSC 732936 5,6-Dihydro-6-(3-dimethylamino-1-propyl)-2,3-methylenedioxy- 5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000416348839396258 0.27477282
NSC 134727 MITOMYCIN C 0.000416348839396261 0.58906259
NSC 39789 Null 0.000463656464354233 0.012278356
NSC 606869 Clofarabine 0.000568922785167333 0.4018561
NSC 618939 Camptothecin Derivative 0.000610795106687085 0.81172842
NSC 681636 Camptothecin Derivative 0.000610795106687085 0.78009748
NSC 681645 Camptothecin Derivative 0.000610795106687085 0.79251594
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.000610795106687085 0.68671162
NSC 735037 Camptothecin Derivative 0.000610795106687085 0.82394201
NSC 757925 3,5-bis(4-hydroxy-3-methoxystyryl)-N-(4-fluorophenyl)-1H-pyrazole-1-carboxamide 0.000610795106687085 0.36978265
Total:99  Current:3    [First] [Prev] [Next] [Last]